­
­
­
­

Inventi Impact: Gastroenterology

Articles

  • Inventi:hgst/22362/17
    Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on\nColonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study
    01-Jan-1970 Research 2017 : April - June
    Neal Shahidi, Laura Gentile, Lovedeep Gondara, Jeremy Hamm, Colleen E McGahan, Robert Enns, Jennifer Telford

    Background and Aims. The Canadian Partnership Against Cancer (CPAC) recommends a fecal immunochemical test- (FIT-)\npositive predictive value (PPV) for all adenomas of �50%. We sought to assess FIT performance among average-risk participants\nof the British Columbia Colon Screening Program (BCCSP). Methods. From Nov-2013 to Dec-2014 consecutive participants\nof the BCCSP were assessed. Data was obtained from a prospectively collected database. A single quantitative FIT (NS-Plus,\nAlfresa Pharma Corporation, Japan) with a cut-off of �10

    How to Cite this Article
    CC Compliant Citation: Neal Shahidi, Laura Gentile, Lovedeep Gondara, et al., â??Correlating Quantitative Fecal Immunochemical Test Results\nwith Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study,â? Canadian\nJournal of Gastroenterology and Hepatology, vol. 2016, Article ID 4650471, 7 pages, 2016. doi:10.1155/2016/4650471, http://\ncreativecommons.org/licenses/by/4.0/.
    Download Full Text